UK stockpiled medicines to combat biological, nuclear and chemical attacks in the wake of 9/11 horrors as they feared further terrorist atrocities
Medicines to combat anthrax, smallpox and the botulism toxin were all bought as part of a £15million spending drive by the Department of Health.